{"slug":"tesamorelin-ppis","verification":{"valid":true,"entries":2,"head":"aa2b1667f7d3da26307e30c7832ebccd85b9dd7b1a5f5e8620df3700a3693dba"},"energy":{"passes":2,"tokens_in":26713,"tokens_out":2974,"tokens_total":29687,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"aa2b1667f7d3da26307e30c7832ebccd85b9dd7b1a5f5e8620df3700a3693dba"},"provenance":[{"ts":"2026-06-29T23:14:59.001Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Ppis\nSlug: tesamorelin-ppis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"PPIs (omeprazole, etc.)\",\"condition_key\":\"ppis\",\"primary_peptide\":\"tesamorelin\",\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[\"ppis\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have PPIs (omeprazole, etc.)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"ppis\",\"name\":\"PPIs (omeprazole, etc.)\",\"section_title\":\"Why PPIs (omeprazole, etc.) matters for you\",\"steps\":[\"**Drug:** PPIs (omeprazole, etc.)\",\"**What it does:** Acid suppression; long-term mucosal and nutrient consequences.\",\"**Therefore for you:** state whether this drug **reduces load**","response":"{\n  \"slug\": \"tesamorelin-ppis\",\n  \"title\": \"Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression\",\n  \"body\": \"## What's breaking down if you have PPIs (omeprazole, etc.)\\n\\nLong-term PPI use suppresses stomach acid production. This reduces symptoms of acid reflux but alters nutrient absorption over months or years. Key layers affected include calcium, magnesium, vitamin B12, and iron uptake. Reduced acid can also change gut microbiome balance and raise infection risks.\\n\\nIf your bone density declines or muscle recovery slows, the chain often traces back to these absorption changes. PPIs do not directly damage tissue but limit the raw materials the body needs for ongoing repair.\\n\\n## Why Tesamorelin might help you\\n\\n1. You are reading about PPIs — acid suppression creates downstream nutrient gaps that can affect metabolism and tissue maintenance.\\n2. Therefore for you: If visceral fat accumulation or reduced lean mass is part of your profile alongside PPI use, Tesamorelin is discussed because it stimulates endogenous growth hormone release that targets fat breakdown and supports lean tissue — not because it restores stomach acid or replaces missing nutrients.\\n\\nTesamorelin acts on the GH axis. Higher GH and IGF-1 levels promote lipolysis in visceral fat stores. This may indirectly ease metabolic load. No data shows it reverses PPI-induced nutrient shortfalls.\\n\\n## Why PPIs (omeprazole, etc.) matters for you\\n\\nDrug: PPIs (omeprazole, etc.)\\nWhat it does: Acid suppression; long-term mucosal and nutrient consequences.\\nTherefore for you: This drug suppresses a signal (gastric acid) to control symptoms. It trades off repair pathways by limiting mineral and vitamin absorption, which can compound degeneration in bone and muscle over time rather than supporting them.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tesamorelin targets the GH axis and visceral fat layer. PPIs handle acid-related symptoms but introduce absorption","tokens_in":26713,"tokens_out":2974,"cost":0,"prev":"genesis","hash":"d4959a2d592ba18b5f696035f396fe0f53255f2006e61a04a4ee56cfadd11812"},{"ts":"2026-07-17T02:42:25.706Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-ppis","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d4959a2d592ba18b5f696035f396fe0f53255f2006e61a04a4ee56cfadd11812","hash":"aa2b1667f7d3da26307e30c7832ebccd85b9dd7b1a5f5e8620df3700a3693dba"}]}